LSX World Congress USA 2022
Event summary
Cooley is proud to co-host the Biotech Growth CEO Forum at LSX's World Congress USA. This event will be a unique, powerful and valuable space for the candid sharing of experience between 25-30 of the sector’s established growth-stage, post-series A biotech executives. Like-minded executives are joined by two appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by a number of executives who have enjoyed success or navigated key challenges in their pursuit of company growth.
Featured agenda item
Trends in Licensing and Collaborations
Tuesday, June 21: 11:45 am – 12:10 pm ET
Cooley partner Alan Tamarelli will be a featured speaker.
Topics include
- Increasing financial terms/inflation
- Scope of licensed fields of use and exclusivity
- Anti-stacking provisions
- Sublicensing revenue and other value sharing
- Reversion licenses and terms, alternatives to termination
- Territory specific transactions
For more information, please email Brendon Fei.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.